Skip to main content

Table 1 Descriptive statistics for each of the ten trials after multiple imputation

From: Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis: an individual participant data meta-analysis

Trial

Bucher

De Sutter

Kaiser

Meltzer

Merenstein

Schering-Plough

Stalman

Varonen

Williamson1

Williamson2

Number of participants

251

368

266

490

135

458

191

150

116

114

Antibiotic assignment (%)

49

49

51

50

50

48

51

59

51

45

Female (%)

54

57

52

66

69

70

64

70

72

76

Age in years, mean (SD)

36.6 (13.1)

38.4 (14.2)

32.8 (11.6)

35.7 (12.2)

33.9 (9.8)

38.7 (14.6)

37.0 (11.4)

39.7 (13.4)

43.3 (15.5)

43.8 (12.7)

Preceding URTI (%)

56

79

35

78

52

76

92

56

71

67

Symptom duration in days median (IQR)

4 (3,7)

6 (3,10)

4 (3,7)

13 (10,19)

9 (7-14)

13 (10,19)

7 (6,14)

5 (3,9)

5 (3,10)

5 (3,7)

Pain on bending (%)

82

69

27

86

81

85

90

78

82

85

Pain in teeth (%)

24

44

14

85

28

81

50

19

37

56

Unilateral facial pain (%)

54

55

14

98

39

98

42

23

52

51

PNDsr (%)

98

88

51

67

84

53

83

48

74

67

Symptom severity,

44.2

50.6

46.0

41.8

43.7

48.5

48.1

55.7

56.2

48.5

median (IQR)

(19.8, 67.8)

(24.4, 62.7)

(15.8, 74.1)

(23.4, 79.6)

(27.0, 78.6)

(28.4, 77.5)

(23.1, 74.7)

(25.7, 76.0)

(27.7, 82.1)

(27.7, 73.1)

Fever (%)

14

7

11

1

1

2

4

18

3

4

PNDex (%)

66

55

33

33

32

31

12

32

39

31

PPDex (%)

21

45

18

45

55

34

9

72

22

25

Cure (%)

69

35

56

69

49

66

65

77

64

65

  1. IQR Interquartile range, PNDex Purulent nasal discharge upon examination, PNDsr Purulent nasal discharge self-reported, PPDex Purulent pharyngeal discharge upon examination, SD Standard deviation, URTI Upper respiratory tract infection. Grey figures relate to systematically missing data